The future of radiation-induced abscopal response: beyond conventional radiotherapy approaches. (Record no. 30904128)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01155 a2200325 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250518100801.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 202103s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1744-8301 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.2217/fon-2020-0063 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Tubin, Slavisa |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20210317 |
| 245 00 - TITLE STATEMENT | |
| Title | The future of radiation-induced abscopal response: beyond conventional radiotherapy approaches. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Future oncology (London, England) |
| Date of publication, distribution, etc. | Jun 2020 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 1137-1151 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Journal Article; Review |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Animals |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Bystander Effect |
| General subdivision | immunology |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Immune Checkpoint Inhibitors |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Immunotherapy |
| General subdivision | methods |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Neoplasms |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Radiotherapy |
| General subdivision | methods |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Yan, Weisi |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Mourad, Waleed F |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Fossati, Piero |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Khan, Mohammad K |
| 773 0# - HOST ITEM ENTRY | |
| Title | Future oncology (London, England) |
| Related parts | vol. 16 |
| -- | no. 16 |
| -- | p. 1137-1151 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.2217/fon-2020-0063">https://doi.org/10.2217/fon-2020-0063</a> |
| Public note | Available from publisher's website |
No items available.